approval · primary record
SUMATRIPTAN
FDA · NDA · 2025-12-09
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-12-09 |
| Brand | IMITREX |
| Sponsor | GLAXOSMITHKLINE |
| Route | NASAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:33:57.063Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:SUMATRIPTAN:2025-12-09
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.